About Clinical ink
Clinical Ink: Revolutionizing the Life Sciences Industry with Innovative Solutions
Clinical Ink is a leading global life science company that specializes in bringing together data, technology, and patient science to revolutionize the way clinical trials are conducted. With a focus on innovation and excellence, Clinical Ink has become a trusted partner for pharmaceutical companies, biotech firms, and contract research organizations (CROs) around the world.
Founded in 2007 by Ed Seguine and Doug Pierce, Clinical Ink has quickly established itself as a leader in the industry. The company's mission is to improve patient outcomes by providing innovative solutions that streamline clinical trial processes while maintaining high levels of accuracy and compliance.
One of Clinical Ink's core strengths is its proprietary eSource platform called SureSource®. This cloud-based platform allows for real-time data capture during clinical trials using electronic source documents (eSource). By eliminating paper-based processes, SureSource® reduces errors and improves efficiency while ensuring regulatory compliance.
In addition to SureSource®, Clinical Ink offers several other innovative solutions designed to improve the clinical trial process. These include:
- eCOA: Electronic Clinical Outcome Assessments (eCOA) allow patients to complete questionnaires electronically rather than on paper. This not only saves time but also improves accuracy by reducing errors caused by illegible handwriting or incomplete responses.
- ePRO: Electronic Patient Reported Outcomes (ePRO) enable patients to report their symptoms or experiences directly into an electronic device such as a tablet or smartphone. This provides real-time data that can be used to monitor patient progress more effectively.
- SitePro: SitePro is an intuitive site management solution that streamlines site workflows and simplifies communication between sites and sponsors/CROs.
Clinical Ink's commitment to innovation has earned it numerous accolades over the years. In 2019 alone, the company was named one of Inc.'s Best Workplaces for 2019, received Frost & Sullivan's North American Technology Innovation Award for eSource Solutions in Life Sciences Industry Leadership Award from Pharma Tech Outlook magazine.
But what truly sets Clinical Ink apart from its competitors is its dedication to patient-centricity. The company understands that patients are at the heart of every clinical trial and strives to make their experience as positive as possible. By leveraging technology such as SureSource®, eCOA, ePROs, SitePro – all designed with patients' needs in mind – Clinical Ink helps ensure that patients remain engaged throughout their participation in clinical trials.
In conclusion,
Clinical ink has become synonymous with innovation within life sciences industry due its cutting-edge solutions like Sure Source®, which have revolutionized how data is captured during clinical trials; this ensures accuracy while reducing errors caused by manual entry methods like paper-based systems which were previously used before these innovations came along! Additionally they offer other innovative solutions such as electronic COAs & PROs which provide real-time monitoring capabilities enabling better tracking progress made towards achieving desired outcomes; this coupled with Site Pro makes managing sites easier than ever before! All these factors combined have helped establish them among top players globally when it comes down delivering quality services tailored specifically towards improving patient outcomes through streamlined processes backed up advanced technologies making them stand out from competition!